About Modulari-T Biosciences

Cell and gene therapies hold immense promise but current approaches are hindered by serious challenges related to toxic side effects and lack the potency and persistence needed for lasting benefit. Manufacturing is long, complex and failure-prone, requiring the patient’s own immune cells to be harvested, engineered in a lab, and reinfused which makes these therapies expensive, inaccessible, and risky.

Modulari-T Bioscience is redefining how cell therapies are made and delivered. Our approach leverages two complementary technologies developed in-house: Modular Actuation Receptor Complexes (MARC) and Modular Vectors (MoVe). MARCs are synthetic immune receptors designed to deliver durable therapeutic effects with reduced toxicity, directly addressing the limitations of current therapies. Instead of complex lab-based manufacturing, we use MoVes protein envelopes to deliver MARC genes directly to target immune cells inside the patient. Th...